CVS Health Corp vs Direxion Daily Semiconductor Bear 3X Shares — how do they compare? CVS Health Corp trades at $86.3 (market cap $112.49B), while Direxion Daily Semiconductor Bear 3X Shares trades at $32.09 (market cap $1.89B). The key difference: CVS Health Corp is far larger — about 59.5× Direxion Daily Semiconductor Bear 3X Shares's market cap, and CVS Health Corp pays a 3.02% dividend while Direxion Daily Semiconductor Bear 3X Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Direxion Daily Semiconductor Bear 3X Shares for 11 Days on average.
| CVS | SOXS | |
|---|---|---|
Market Cap | $112.49B | $1.89B |
Volume | 8,467,392 | 66,118,733 |
Sector | Health | Leveraged / Inverse |
52-Week High | $110.60 | $988.00 |
52-Week Low | $70.08 | $29.62 |
Typical Hold Time | 83 Days | 11 Days |
Enterprise Value | $174.83B | — |
Dividend Yield | 3.02% | — |
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 26% upside. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 estimate. Revenue growth remains solid at $402.07 billion for 2025, though net margins compressed to 1.18%. Technical indicators show a bullish overall signal with support at $87 and resistance at $89.
The outlook remains positive given CVS's dominant market position and Medicare expansion plans, but investors face risks from reimbursement pressures and ongoing legal investigations. Earnings growth and successful execution of healthcare services integration represent the primary catalysts for continued stock appreciation.
SOXS, the Direxion Daily Semiconductor Bear 3X ETF, trades at $30.645, up 3.43% today, reflecting its inverse leveraged exposure to semiconductor stocks. The technical outlook is bearish, with moving averages signaling strong selling pressure, while oscillators are neutral. Recent news highlights the fund's volatility and tactical use during semiconductor sector weakness, as seen in July 2026 when it surged on chip stock declines. A 1:10 stock split occurred on July 15, 2026, adjusting share structure.
The outlook for SOXS remains highly speculative, suited only for short-term traders betting against semiconductors. Key risks include the fund's decay from daily rebalancing, reliance on sector volatility, and persistent AI demand supporting chip stocks. Investors should avoid long-term holdings due to structural erosion and elevated loss potential in rising markets.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXS →